UniProt ID | F207A_HUMAN | |
---|---|---|
UniProt AC | Q9NSI2 | |
Protein Name | Protein FAM207A | |
Gene Name | FAM207A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 230 | |
Subcellular Localization | ||
Protein Description | ||
Protein Sequence | MGKVRGLRARVHQAAVRPKGEAAPGPAPPAPEATPPPASAAGKDWAFINTNIFARTKIDPSALVQKLELDVRSVTSVRRGEAGSSARSVPSIRRGAEAKTVLPKKEKMKLRREQWLQKIEAIKLAEQKHREERRRRATVVVGDLHPLRDALPELLGLEAGSRRQARSRESNKPRPSELSRMSAAQRQQLLEEERTRFQELLASPAYRASPLVAIGQTLARQMQLEDGGQL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Ubiquitination | VRGLRARVHQAAVRP CCHHHHHHHEEECCC | 3.71 | 22817900 | |
16 | Ubiquitination | ARVHQAAVRPKGEAA HHHHEEECCCCCCCC | 13.93 | 22817900 | |
19 | Sumoylation | HQAAVRPKGEAAPGP HEEECCCCCCCCCCC | 59.84 | - | |
19 | Ubiquitination | HQAAVRPKGEAAPGP HEEECCCCCCCCCCC | 59.84 | 29967540 | |
19 | Sumoylation | HQAAVRPKGEAAPGP HEEECCCCCCCCCCC | 59.84 | - | |
19 | Acetylation | HQAAVRPKGEAAPGP HEEECCCCCCCCCCC | 59.84 | 26051181 | |
21 | Ubiquitination | AAVRPKGEAAPGPAP EECCCCCCCCCCCCC | 48.02 | 22817900 | |
34 | Phosphorylation | APPAPEATPPPASAA CCCCCCCCCCCCHHC | 34.37 | 29255136 | |
39 | Phosphorylation | EATPPPASAAGKDWA CCCCCCCHHCCCCCE | 25.15 | 30266825 | |
43 | Ubiquitination | PPASAAGKDWAFINT CCCHHCCCCCEEECC | 45.42 | - | |
50 | Phosphorylation | KDWAFINTNIFARTK CCCEEECCCCCCCCC | 25.52 | 22210691 | |
57 | Ubiquitination | TNIFARTKIDPSALV CCCCCCCCCCHHHHH | 39.29 | - | |
66 | Ubiquitination | DPSALVQKLELDVRS CHHHHHHHHCCCEEC | 36.13 | - | |
72 | Methylation | QKLELDVRSVTSVRR HHHCCCEECCEEEEC | 25.69 | - | |
73 | Phosphorylation | KLELDVRSVTSVRRG HHCCCEECCEEEECC | 29.60 | 30576142 | |
75 | Phosphorylation | ELDVRSVTSVRRGEA CCCEECCEEEECCCC | 23.81 | 23312004 | |
76 | Phosphorylation | LDVRSVTSVRRGEAG CCEECCEEEECCCCC | 16.09 | 30576142 | |
84 | Phosphorylation | VRRGEAGSSARSVPS EECCCCCCCCCCCHH | 28.07 | - | |
85 | Phosphorylation | RRGEAGSSARSVPSI ECCCCCCCCCCCHHH | 27.12 | - | |
88 | Phosphorylation | EAGSSARSVPSIRRG CCCCCCCCCHHHHCC | 37.79 | 21406692 | |
90 | Ubiquitination | GSSARSVPSIRRGAE CCCCCCCHHHHCCCH | 25.86 | 24816145 | |
91 | Phosphorylation | SSARSVPSIRRGAEA CCCCCCHHHHCCCHH | 26.94 | 26074081 | |
99 | Ubiquitination | IRRGAEAKTVLPKKE HHCCCHHCCCCCHHH | 30.58 | - | |
103 | Ubiquitination | AEAKTVLPKKEKMKL CHHCCCCCHHHHHHH | 41.14 | 22817900 | |
103 (in isoform 2) | Ubiquitination | - | 41.14 | 21906983 | |
105 | Ubiquitination | AKTVLPKKEKMKLRR HCCCCCHHHHHHHHH | 61.70 | 24816145 | |
108 | Ubiquitination | VLPKKEKMKLRREQW CCCHHHHHHHHHHHH | 5.32 | 22817900 | |
108 (in isoform 2) | Ubiquitination | - | 5.32 | 21906983 | |
113 | Ubiquitination | EKMKLRREQWLQKIE HHHHHHHHHHHHHHH | 39.41 | 22817900 | |
118 | Sumoylation | RREQWLQKIEAIKLA HHHHHHHHHHHHHHH | 40.10 | - | |
118 | Acetylation | RREQWLQKIEAIKLA HHHHHHHHHHHHHHH | 40.10 | 26051181 | |
118 (in isoform 1) | Ubiquitination | - | 40.10 | 21906983 | |
118 | Sumoylation | RREQWLQKIEAIKLA HHHHHHHHHHHHHHH | 40.10 | - | |
118 | Ubiquitination | RREQWLQKIEAIKLA HHHHHHHHHHHHHHH | 40.10 | 21906983 | |
123 (in isoform 1) | Ubiquitination | - | 49.01 | 21906983 | |
123 | Ubiquitination | LQKIEAIKLAEQKHR HHHHHHHHHHHHHHH | 49.01 | 22817900 | |
128 | Ubiquitination | AIKLAEQKHREERRR HHHHHHHHHHHHHHH | 35.81 | 22817900 | |
138 | Phosphorylation | EERRRRATVVVGDLH HHHHHHCEEEECCCH | 16.42 | 29978859 | |
161 | Phosphorylation | LLGLEAGSRRQARSR HHCCCCCCHHHHHHH | 31.19 | 23917254 | |
170 | Phosphorylation | RQARSRESNKPRPSE HHHHHHHCCCCCHHH | 49.39 | 25954137 | |
172 | Ubiquitination | ARSRESNKPRPSELS HHHHHCCCCCHHHHH | 52.24 | - | |
176 | Phosphorylation | ESNKPRPSELSRMSA HCCCCCHHHHHHCCH | 53.07 | 29214152 | |
179 | Phosphorylation | KPRPSELSRMSAAQR CCCHHHHHHCCHHHH | 23.14 | 25954137 | |
203 | Phosphorylation | RFQELLASPAYRASP HHHHHHHCCHHHCCH | 15.27 | 30266825 | |
206 | Phosphorylation | ELLASPAYRASPLVA HHHHCCHHHCCHHHH | 15.31 | 30266825 | |
209 | Phosphorylation | ASPAYRASPLVAIGQ HCCHHHCCHHHHHHH | 15.12 | 21815630 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of F207A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of F207A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of F207A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of F207A_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-34 AND SER-203, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-34 AND SER-203, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-34, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-34, AND MASSSPECTROMETRY. |